Conium Maculatum Gtte 4ch-30ch 4 Ch Drops is a Health Canada–registered human drug (DIN 00884901) held by Phyto-Sante Ltée, containing Conium Maculatum. Health Canada lists its status as Cancelled Post Market (status date 28 Oct 2003). Nexara Health has matched 13 registrations of Conium Maculatum across 2 other regulated markets.
Health Canada registration
| DIN | 00884901 |
|---|---|
| Brand name | Conium Maculatum Gtte 4ch-30ch |
| Active ingredient | Conium Maculatum |
| Strength | 4 Ch |
| Dosage form | Drops |
| Route | Oral |
| Company | Phyto-Sante Ltée |
| Status | Cancelled Post Market — 28 Oct 2003 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Conium Maculatum registered in other markets
13 registrations of the same molecule in 2 national registries outside Canada (first 9 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United Arab Emirates | Conium Maculatum - Boiron | BOIRON, France, Messimy | 2 DH - 200 CH | Pillules | Active | EDE |
| United States | Bestmade Natural Products Conium Maculatum | Bestmade Natural Products | Tablet, Soluble | listed | FDA NDC | |
| United States | Conium Maculatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Conium Maculatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Conium Maculatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Conium Maculatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Conium Maculatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Conium Maculatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Conium Maculatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Conium Maculatum worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Conium Maculatum Gtte 4ch-30ch (DIN 00884901) marketed in Canada?
No. Health Canada lists DIN 00884901 as Cancelled Post Market as of 28 Oct 2003.
Who holds the Canadian licence for this product?
Phyto-Sante Ltée is the company of record in the Health Canada Drug Product Database.
Is Conium Maculatum registered outside Canada?
Yes — Nexara Health has matched 13 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00884901, status date 2003-10-28; national medicine registries: EDE, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00884901, status date 2003-10-28; national medicine registries: EDE, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 00884901, status date 2003-10-28; national medicine registries: EDE, FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.